Evaluation of cis-diamminedichloroplatinum(II) combined with metoclopramide or sodium thiosulfate on L1210 leukemia in vitro and in vivo Joseph J. CatinoDonna M. FrancherJohn E. Schurig Original Articles Pages: 1 - 4
Noninvasive fluorine-19 NMR study of fluoropyrimidine metabolism in cell cultures of human pancreatic and colon adenocarcinoma Marie-C. Malet-MartinoFrançoise FaureRobert Martino Original Articles Pages: 5 - 10
A cellular analysis of long-term haematopoietic damage in mice after repeated treatment with cyclophosphamide Graham MolineuxChengxiong XuNydia Garcia Testa Original Articles Pages: 11 - 16
Calcium antagonism by the antioestrogen tamoxifen A. LiptonI. D. Morris Original Articles Pages: 17 - 20
The antiproliferative properties of tamoxifen and phenothiazines may be mediated by a unique histamine receptor (?H3) distinct from the calmodulin-binding site Lorne J. BrandesR. Patricia BogdanovicRatna Bose Original Articles Pages: 21 - 23
Etoposide in prostatic cancer: experimental studies and phase II trial in patients with bidimensionally measurable disease Howard I. ScherCora Sternbergthe Community Cancer Oncology Program Investigators Original Articles Pages: 24 - 26
Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy S. J. P. Van BelleM. M. de PlanqueJ. G. McVie Original Articles Pages: 27 - 32
Phase I clinical and pharmacokinetic study of cyclophosphamide administered by five-day continuous intravenous infusion N. Simon TchekmedyianMerrill J. EgorinJoseph Aisner Original Articles Pages: 33 - 38
Pharmacokinetic and endocrinological parameters of a slow-release depot preparation of the GnRH analogue ICI 118630 (Zoladex) compared with a subcutaneous bolus and continuous subcutaneous infusion of the same drug in patients with prostatic cancer Timothy J. PerrenRichard N. ClaytonClive H. Young Original Articles Pages: 39 - 43
A phase I study of vinblastine tryptophan ester F. CeulemansY. HumbletA. Trouet Original Articles Pages: 44 - 46
Biliary excretion and pharmacokinetics of 4'epidoxorubicin (epirubicin) in advanced cancer patients Carlo M. CamaggiElena StrocchiFranco Pannuti Original Articles Pages: 47 - 50
EVA treatment for recurrent or unresponsive Hodgkin's disease M. A. RichardsJ. H. WaxmanT. A. Lister Original Articles Pages: 51 - 53
A phase II study of human rDNA alpha-2 interferon in patients with low grade non-Hodgkin's lymphoma J. WagstaffP. LoyndsD. Crowther Original Articles Pages: 54 - 58
Treatment of acute leukaemia with m-AMSA in combination with cytosine arabinoside H. S. DhaliwalM. S. ShannonT. A. Lister Original Articles Pages: 59 - 62
A toxicity study of recombinant interferon-gamma given by intravenous infusion to patients with advanced cancer Kumar SriskandanPhilip GarnerDudley E. H. Tee Original Articles Pages: 63 - 68
Cumulative renal tubular damage associated with cisplatin nephrotoxicity Marshall P. GorenReba K. WrightMarc E. Horowitz Original Articles Pages: 69 - 73
High-dose cis-platinum combination chemotherapy in advanced nonseminomatous malignant germ cell tumours with emphasis on nephrotoxicity Kirsten Sundby HallSophie Dorothea FossåMagne Aas Original Articles Pages: 74 - 77
Cellular and plasma pharmacokinetics of weekly 20-mg 4′-epi-adriamycin bolus injection in patients with advanced breast carcinoma P. A. J. SpethP. C. M. LinssenC. Haanen Original Articles Pages: 78 - 82
Decreased autolysis of dead cells in Adriamycin-resistant lines of the sarcoma 180 of mouse J. ŠonkaA. GüntherM. Volm Short Communication Pages: 83 - 85
Anti-emetic efficacy of dexamtheasone in combination for out-patients receiving cytotoxic chemotherapy Simon G. AllanDonald F. FarquharRobert C. F. Leonard Short Communication Pages: 86 - 87
A phase II antiemetic combination (COMD) for cisplatin-induced nausea and vomiting Fausto RoilaCarlo BasurtoMaurizio Tonato Short Communication Pages: 88 - 89
The effect of food on the oral administration of 6-mercaptopurine Neil K. BurtonMichael J. BarnettT. Andrew Lister Short Communication Pages: 90 - 91
Cisplatin induces modulation of transferrin receptor during cellular differentiation in vitro G. P. ToniniM. T. ParodiP. Cornaglia-Ferraris Letter to the Editors Pages: 92 - 92